View Document Preview and Link Open Document File Size: 852,32 KB Share Result on Facebook
City Osaka / Taudorf / / Company Fleming / IgG / Life Technologies / GenBank / Millipore / Sigma-Aldrich / GraphPad Software / TOYOBO / Creative Commons / Anderson SA / Efe / / Country Japan / United States / China / / / Event FDA Phase / / Facility Second Military Medical University / Changhai Hospital / / IndustryTerm transportation / treatment of anemia associated disease / therapy of the resulting iron metabolism disorders / described protocol / / MedicalCondition Hereditary hemochromatosis / TB / HAMP-overexpressionrelated diseases / iron deficiency anemia / HAMP-overexpression-related diseases / inflammatory cytokines / disorder / MS / Goodnough LT. Anemia / iron-linked disorders / iron deficiency / iron metabolism disorders / cancer / disease / kidney disease / promoterless luciferase ORF / hepatoma derived cells / diabetes / chronic disease / infection / inflammation / ironoverload disorders / iron metabolism disorder / HuH7 hepatoma cells / acute infection / anemia / / Organization Department of General Surgery / Hematology American Society of Hematology Education Program / Hematology/American Society of Clinical Oncology / Changhai Hospital / Second Military Medical University / Shanghai / American Society / Shanghai Municipal Natural Science Foundation / / Person ACA GTG GCT TAT GCC / Guang-Hua Rong / Wen Wen / / / Position mediator / HAMP promoter luciferase reporter / Carpenter / Dual-Luciferase Reporter / author / luciferase reporter / reporter / / Product penicillin / BMP-2 / M-113 / TRIzol® Reagent / / RadioStation Pendas AM / Lara FM / / Technology BMP / siRNA / antibodies / Directed Mutagenesis / Cell Signaling / stem cells / DNA binding / ATG / previously described protocol / gene expression / DNA sequencing / CAT / Gui / / URL http / 
Sox2 function as a negative regulator to control HAMP expression